http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102289971-B1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-333 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-326 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-105 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-258 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-105 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-258 |
filingDate | 2019-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2021-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2021-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-102289971-B1 |
titleOfInvention | Pharmaceutical composition comprising the oil fraction of seed extract of panax ginseng c. a. meyer as an effective component for prevention or treatment of thrombosis and health functional food comprising the same |
abstract | The present invention relates to a pharmaceutical composition and health functional food for the prevention or treatment of thrombosis containing an oil layer of ginseng seed (Seed of Panax ginseng CA Meyer) extract as an active ingredient, and more specifically, to It relates to a pharmaceutical composition for preventing or treating/improving thrombosis through inhibition of blood coagulation and inhibition of platelet aggregation and a health functional food using an oil layer produced after concentration of an ethanol extract under reduced pressure as an active ingredient. The oil layer of ginseng seed ethanol extract as an active ingredient of the pharmaceutical composition for the prevention or treatment of thrombosis of the present invention and a health functional food is a platelet that plays a role in initiating thrombus formation along with inhibition of thrombus formation-related enzymes and blood coagulation factors. It exhibits strong antithrombotic activity due to its aggregation inhibitory effect, has excellent thermal stability, and does not show any loss of coagulation factor inhibitory effect and thrombus formation-related enzyme inhibitory effect even in acidic conditions of pH 2 and plasma. It is expected to be used for the prevention and treatment of thrombosis such as ischemic stroke and hemorrhagic stroke, and the active ingredient is processed into various forms such as extracts, powders, pills, tablets, etc. Because it is effective, it is a very useful invention in the pharmaceutical industry and the food industry. |
priorityDate | 2019-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 128.